US pet insurance passes $1.5B in Q1 as competition builds
Bottom line
US pet insurance is getting bigger, and more crowded. Quarterly premiums reached $1.53 billion in the first quarter of 2026, up 16.8% from a year earlier, according to an analysis cited by GlobalPETS. Trupanion remained the top U.S. underwriter, while JAB Holdings moved into the No. 2 spot as its pet insurance platform continued to scale through acquisitions and multiple brand relationships. The broader market backdrop still looks favorable: NAPHIA says North America ended 2025 with 7.6 million insured pets and $6.2 billion in gross written premium, while U.S. penetration remains relatively low, leaving room for further expansion. (spglobal.com)
Why it matters: For veterinary professionals, a larger insured population can mean fewer cost-driven compromises in care. A 2026 Pawlicy Advisor-AAHA survey reported that 85.6% of veterinary respondents saw positive differences between insured and uninsured patients, including better treatment compliance and less economic euthanasia. But a more competitive insurance market could also mean more plan variation, more client questions, and more pressure on practices to help pet parents navigate coverage without crossing into insurance solicitation. (dvm360.com)
What to watch: Watch whether newer scale players such as JAB-backed Independence Pet Group and fast-growing Lemonade keep taking share from legacy carriers as regulators and practices adapt to a more visible, more scrutinized pet insurance category. (spglobal.com)
The U.S. pet insurance market crossed another threshold in early 2026, with quarterly premiums reaching $1.53 billion in Q1, up 16.8% year over year, according to the market analysis highlighted by GlobalPETS. The headline inside the headline is competitive positioning: Trupanion kept its lead, but JAB Holdings rose to second place, signaling that consolidation and multi-brand scale are starting to reshape the field. (globalpetindustry.com)
That momentum builds on several years of rapid expansion, even as growth has begun to normalize. NAPHIA’s 2026 State of the Industry report says North America finished 2025 with 7.6 million insured pets and $6.2 billion in gross written premium, up 19.4% from 2024. S&P Global separately reported that U.S. net premiums earned hit a record $3.59 billion in 2025, though the annual growth rate slowed to 11% from 26.6% the year before. In other words, the market is still growing fast, just not at the breakneck pace seen earlier in the cycle. (naphia.org)
The competitive story matters because it’s no longer just about one or two familiar names. S&P Global’s review of 2025 statutory data found Trupanion at $1.22 billion in direct premiums written, while Nationwide’s direct premiums written fell 6.4% to $956.3 million as it pulled back. JAB ranked third in that 2025 snapshot, but posted the fastest growth, up 79.9% year over year. Its platform has been built through a series of deals and brand relationships: JAB’s 2022 acquisition of Fairfax’s pet insurance operations added Crum & Forster Pet’s underwriting and servicing relationships, including ASPCA Pet Health Insurance, Spot, Pumpkin, Hartville, and other brands under the broader platform umbrella. (spglobal.com)
That helps explain why competitive intensity appears to be rising even though pet insurance penetration is still modest. JAB’s Independence Pet Group already described itself as an integrated, full-stack platform with nationwide underwriting capability and multiple consumer and partner brands. Lemonade is also pressing into the category; GlobalPETS reported its pet portfolio exceeded $500 million in in-force premium by the end of Q1 2026. At the same time, regulators are paying closer attention. Pet insurance was carved out as its own statutory line of business beginning with 2024 reporting changes, and NAIC has since added pet insurance to newer market conduct reporting and examination workstreams. (independencepetgroup.com)
Industry reaction from the veterinary side points to why this matters beyond insurer rankings. In a September 10, 2026, report on the latest Pawlicy Advisor-AAHA survey, dvm360 said 85.6% of veterinary respondents observed positive differences between insured and uninsured patients. The most commonly cited benefit was better treatment compliance, followed by better patient outcomes and less economic euthanasia. The same survey found practices still adjust recommended treatment plans for cost an average of 5.1 times per week, and that practices recommending insurance proactively reported a higher median insured share than those waiting for pet parents to ask. (dvm360.com)
Why it matters: More competition could be good news for veterinary teams if it expands enrollment, improves product fit, or tempers premium inflation. Low penetration remains the core growth argument; GlobalPETS reported U.S. penetration reached 4.3% in 2025, with higher uptake in dogs than cats. For practices, even small gains in insured share can affect case acceptance, treatment planning, and the frequency of financially constrained euthanasia decisions. But competition also brings complexity. More brands, white-label products, and underwriting structures can make it harder for teams to answer pet parent questions consistently, especially since most veterinary professionals aren’t licensed to sell property and casualty insurance. (globalpetindustry.com)
There’s also a practical business angle. As the category matures, insurers and distributors are likely to compete harder for clinic relationships, employer channels, breeders, shelters, and digital acquisition. That may create more educational tools and comparison resources for practices, but it may also raise expectations that veterinary teams help explain coverage, exclusions, and reimbursement differences. The opportunity is real, though so is the need for guardrails around compliance and staff workload. (businesswire.com)
What to watch: The next signals will be market share shifts in 2026 statutory data, whether Nationwide’s pullback continues, how quickly JAB-backed brands and Lemonade keep growing, and whether increased regulatory standardization makes products easier for practices and pet parents to compare. (spglobal.com)